BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pharmaceutical Formulations, Inc. 

460 Plainfield Avenue

Edison  New Jersey  08818  U.S.A.
Phone: 732-985-7100 Fax: 732-819-3330


SEARCH JOBS




Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
Pharmaceutical Formulations (PHFR) Announces The Resignation Of Its President And COO10/19/2005 5:13:04 PM
Pharmaceutical Formulations (PHFR) Announces Completion Of Sale Of Assets To Leiner Health Products10/19/2005 5:12:58 PM
Pharmaceutical Formulations (PHFR) Announces Results For The Nine Months Ended October 2, 2004 10/19/2005 5:12:14 PM
Pharmaceutical Formulations's (PHFR) Konsyl Pharmaceuticals Division Introduces SennaPrompt10/19/2005 5:11:34 PM
Pharmaceutical Formulations (PHFR) Announces Net Sales Increase Of 13.2% For First Quarter 200410/19/2005 5:11:25 PM
Pharmaceutical Formulations (PHFR) Announces Appointment Of Brian Bradley As Executive Vice President10/19/2005 5:11:07 PM
Pharmaceutical Formulations (PHFR) Announces Flat Sales For Fiscal Year 200410/19/2005 5:11:02 PM
Pharmaceutical Formulations (PHFR) Announces Increased Sales And Operating Results For The Quarter And Nine Months Ended September 27, 2003 And Agreement For Development Of ANDAs For Generic Prescription Strength Products10/19/2005 5:10:45 PM
Pharmaceutical Formulations (PHFR) Announces Sales Increase Of 21.6% For Fiscal Year 200310/19/2005 5:10:42 PM
Pharmaceutical Formulations (PHFR) Announces Financial Results For Six Months Ended July 3, 200410/19/2005 5:10:41 PM
12